ASLAN Pharmaceuticals Lim... (ASLN)

AI Score

Unlock

0.60

-0.10 (-14.27%)

At close: Jul 18, 2024, 8:00 PM

0.56

-6.67%

After-hours: Jul 18, 2024, 07:58 PM EDT

ASLAN Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q4 2020	Q3 2020	Q2 2020	Q4 2019	Q3 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Sep 30, 2023	Jul 6, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Dec 31, 2019	Sep 30, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-9.71M	-1.87M	-19.11M	-14.48M	-10.93M	-5.95M	-3.7M	-3.96M	-29.59M	-5.26M	-11.75M	-11.86M	-10.33M	-8.79M	-15.35M	-7.9M	-9.18M	-8.27M	-6.73M	5.05M	-3.36M	-3.97M
Depreciation & Amortization	n/a	n/a	n/a	-2.37M	n/a	72.75K	74K	2.19M	84.91K	104.28K	65.87K	65.27K	55.14K	58.72K	61.84K	57.35K	53.27K	41.84K	32.16K	16.03K	14.23K	13.08K
Stock-Based Compensation	n/a	n/a	n/a	336.25K	n/a	147.12K	31.73K	n/a	256.33K	-367.98K	-483.83K	819.96K	229.56K	756.52K	494.05K	244.85K	273.15K	270.72K	154.77K	617.18K	382.38K	258.47K
Other Working Capital	n/a	n/a	n/a	103.78M	n/a	-132.29K	645.03K	n/a	910.21K	-260.26K	82.8K	277.39K	129.03K	-776.52K	501.93K	486.53K	329.94K	-1.21M	654.72K	226.25K	230.66K	-491.87K
Other Non-Cash Items	9.71M	1.87M	19.11M	14.48M	10.93M	348.78K	220.54K	105.94M	286.92K	78.28K	121.77K	14.02K	-407.34K	303.22K	828.53K	334.61K	155.57K	396.07K	100.2K	82.67K	149.62K	164.5K
Deferred Income Tax	n/a	n/a	n/a	-108.51M	n/a	389.26K	137.36K	n/a	23.36M	-128.11K	-193.69K	7.96K	-382.06K	190.33K	436.57K	401.91K	157.7K	293.33K	-40.88K	16.36K	n/a	n/a
Change in Working Capital	n/a	n/a	n/a	104.3M	n/a	-42.81K	1.46M	-104.17M	546.82K	-1.6M	1.86M	442.18K	1.22M	-2.39M	3.28M	-1.55M	-272.6K	1.49M	1.38M	571.13K	-685.28	-502.6K
Operating Cash Flow	n/a	n/a	n/a	-6.24M	n/a	-5.04M	-1.77M	n/a	-5.06M	-7.05M	-10.19M	-10.52M	-9.24M	-10.06M	-10.69M	-8.82M	-8.97M	-6.08M	-5.06M	6.33M	-2.81M	-4.04M
Capital Expenditures	n/a	n/a	n/a	1.00	n/a	n/a	-5.06K	n/a	1.00	-1	-427.83K	-793.19K	-10.18M	-12.09M	-15.29K	-23.1K	-251.5K	-16.55K	-157.02K	-256.68K	-7.66K	-32.66K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-30.21K	n/a	6.09K	-465	n/a	1.53K	36.73K	-408.9K	-881.32K	-10.07M	-12.07M	5.63K	-100.7K	114.53K	-53.28K	-57.42K	-1.4K	-70.17K	-18.63K
Investing Cash Flow	n/a	n/a	n/a	-30.21K	n/a	6.09K	-5.52K	n/a	1.53K	36.73K	-422.98K	-909.08K	-10.08M	-12.09M	-9.48K	-114.96K	-136.98K	-69.83K	-141.33K	-258.17K	-77.91K	-43.33K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	9.11M	n/a	7.3M	5.29K	-1.9M	19.27M	-44.55K	4.6M	847.13K	n/a	n/a	1.04M	-29.9K	32.79M	n/a	-1.06M	14.16M	8.88M	9.43M
Financial Cash Flow	n/a	n/a	n/a	9.11M	n/a	7.3M	5.29K	-1.9M	19.27M	-44.55K	4.6M	847.13K	n/a	n/a	1.04M	-29.9K	32.79M	n/a	-1.06M	14.16M	8.88M	9.43M
Net Cash Flow	-124.81K	-16.55M	594.46K	-850.75K	-3.82M	2.26M	-1.77M	-1.9M	14.21M	-7.06M	-5.88M	-9.95M	16.19M	-23.16M	-10.05M	-9.17M	23.92M	-9.36M	-5.94M	18.83M	6.16M	5.07M
Free Cash Flow	n/a	n/a	n/a	-6.24M	n/a	-5.04M	-1.77M	n/a	-5.06M	-7.05M	-10.62M	-11.31M	-19.42M	-22.16M	-10.71M	-8.84M	-9.22M	-6.09M	-5.21M	6.08M	-2.82M	-4.07M